Q3 looks set to be another strong quarter supported by recent acquisitions and with the Oras legacy contracts now finalised. We forecast 10.8% sales growth YOY in Q3, with 29bp EBIT margin expansion, implying 16% YOY adjusted EBIT growth. With the outlook for stable markets and a healthy order backlog supporting organic growth, the asset-light model should continue to deliver strong FCF. This indicates ample financial resources for further M&A, with 15 acquisitions completed YTD. We reiterate BU...
A mixed Q2 saw still-strong order intake but weaker sales and profit margins, although we continue to see a multi-year Nordic market consolidation case unfolding, with Bravida the prime consolidator. With the outlook for stable markets, and a record order backlog supporting organic growth, the asset-light model should continue to generate strong FCF. This indicates ample financial resources for further M&A, with 12 acquisitions closed YTD. We reiterate our BUY and SEK92 target price.
Q2 looks set to be another strong quarter, even as the last of Oras’ legacy contracts are finalised, as we forecast 8% YOY adjusted EBIT growth. With the outlook for stable markets and a healthy order backlog supporting organic growth, the asset-light model should continue to deliver strong FCF. This indicates ample financial resources for further M&A, with 11 acquisitions already announced YTD. We reiterate our BUY and SEK92 target price.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.